Fair Isaac Corporation
NYSE:FICOSoftware - Application
-$39.14 today
- Market cap
- $14.49B
- Beta
- 1.28
- P/E (TTM)
- 33.8
- EPS (TTM)
- $32.15
Volume 0.47M
Average 0.37M
FICO Pre-Tax Margin
Income before tax as a percentage of revenue.
Fair Isaac CorporationNYSE: FICO
Pre-Tax Margin · Q3 FY2026 · quarter ended Jun 2026
Pre-tax margin widens to 46.7%
Pre-tax margin was 46.7% in Q3 FY2026, up 2.5 pp from a year earlier. On a trailing-twelve-month basis it was 44.5%, up 4.5 pp year over year. Over 3 fiscal years it widened by 6.1 pp.
Context
- Pre-tax margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Pre-Tax Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 40.3%
- Year-over-year change
- +2.9pp
| Period | Period end | Pre-Tax Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 40.3% | +2.9pp |
| FY2024 | 2024-09-30 | 37.4% | +0.8pp |
| FY2023 | 2023-09-30 | 36.6% | +2.4pp |
| FY2022 | 2022-09-30 | 34.2% | -1.7pp |
| FY2021 | 2021-09-30 | 35.9% | — |
Pre-Tax Margin vs competitors
How FICO compares with its peers on the latest reported figures
- FICO's LTM Jun 2026 pre-tax margin of 44.5% is the highest of the 5 companies compared; the peer median is 15.9%.
- Its year-over-year change of +4.5 pp is the 3rd highest of 5, against a peer median of +1.5 pp.
- Over three fiscal years its change of +6.1 pp compares with a peer median of +5.9 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Jun 2026 | 44.5% | +4.5 pp | +6.1 pp | |
| LTM Jun 2026 | 20.1% | -3.3 pp | +8.1 pp | |
| LTM Jun 2026 | 18.8% | +6.3 pp | +3.7 pp | |
| LTM Sep 2026 | 13.1% | -5.3 pp | +2.9 pp | |
| LTM Jul 2026 | 5.3% | +9.4 pp | +25.1 pp | |
| Peer median (excluding FICO) | 15.9% | +1.5 pp | +5.9 pp | |
Competitors are the stored peer set for FICO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 1.32B | 1.38B | 1.51B | 1.72B | 1.99B |
| Cost of Revenue | 332.46M | 302.17M | 311.05M | 348.21M | 353.72M |
| Gross Profit | 984.07M | 1.08B | 1.2B | 1.37B | 1.64B |
| Gross Margin | 74.7% | 78.1% | 79.4% | 79.7% | 82.2% |
| Research & Development | 171.23M | 146.76M | 159.95M | 171.94M | 188.35M |
| Selling, General & Admin | 396.28M | 383.86M | 400.57M | 462.83M | 513.03M |
| Operating Expenses | 478.59M | 532.68M | 559.67M | 635.69M | 712.3M |
| Depreciation & Amortization | 25.59M | 20.47M | 14.64M | 13.83M | 14.95M |
| EBITDA | 538.83M | 560.74M | 663.81M | 761.49M | 951.19M |
| EBITDA Margin | 40.9% | 40.7% | 43.9% | 44.3% | 47.8% |
| Operating Income | 505.49M | 542.41M | 642.83M | 733.63M | 924.85M |
| Operating Margin | 38.4% | 39.4% | 42.5% | 42.7% | 46.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 40.09M | 68.97M | 95.55M | 105.64M | 133.65M |
| Other Income / Expenses | (32.35M) | (71.11M) | (89.21M) | (91.6M) | (122.26M) |
| Income Before Tax | 473.14M | 471.31M | 553.62M | 642.03M | 802.6M |
| Pre-Tax Margin | 35.9% | 34.2% | 36.6% | 37.4% | 40.3% |
| Income Tax Expense | 81.06M | 97.77M | 124.25M | 129.21M | 150.65M |
| Net Income | 392.08M | 373.54M | 429.38M | 512.81M | 651.95M |
| Net Margin | 29.8% | 27.1% | 28.4% | 29.9% | 32.7% |
| EPS (Basic) | 13.65 | 14.34 | 17.18 | 20.78 | 26.90 |
| EPS (Diluted) | 13.40 | 14.18 | 16.93 | 20.45 | 26.54 |
| Weighted Avg Shares | 28.73M | 26.04M | 24.99M | 24.68M | 24.24M |
| Weighted Avg Shares (Diluted) | 29.26M | 26.35M | 25.37M | 25.08M | 24.56M |
Fair Isaac Corporation
NYSE:FICO
Intrinsic Alpha fair value
Locked
Current Price
$677.75
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.